Effectiveness of Butylphthalide on Dynamic Cerebral Autoregulation in Patients With Acute Ischemic Stroke.
Status:
Recruiting
Trial end date:
2022-12-25
Target enrollment:
Participant gender:
Summary
This is a randomized, triple-blind, placebo-controlled, multicenter clinical trial.
investigators plan to enroll 774 eligible patients, which will be randomized into either the
butylphthalide (NBP) or placebo group in a 2:1 ratio.The main purpose of this study is to
determine whether butylphthalide can improve dynamic Cerebral Autoregulation (dCA) in
large-artery atherosclerosis acute ischemic stroke.